Resilience is creating an ecosystem for advanced biopharmaceutical manufacturing. They provide a network of high-tech, end-to-end manufacturing and development solutions to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale. Resilience offers customized and scalable processes, the highest quality and regulatory capabilities, and world-class talent and facilities for complex and novel medicines. This includes cell and gene therapies, viral vectors, vaccines, proteins, and new discoveries. Resilience offers a broad mix of customized manufacturing capabilities to serve the needs of biopharmaceutical partners at all stages of the drug development process -- from pre-clinical development to commercial supply.